Hemostasis induction

Hemostasis induction refers to the complex physiological or pharmacological process of arresting hemorrhage by promoting blood clot formation at the site of vascular injury. It is not a single molecular target but a coordinated biological response involving immediate vascular constriction, the formation of a temporary platelet plug (primary hemostasis), and the activation of a complex enzyme cascade resulting in a stable fibrin mesh (secondary hemostasis) [1][4]. In a therapeutic context, hemostasis induction is the primary objective in managing acute trauma, surgical bleeding, and inherited coagulation disorders such as hemophilia [1]. Pharmacological intervention typically involves the use of antifibrinolytics to prevent the breakdown of existing clots or the administration of exogenous clotting factors to supplement deficiencies in the coagulation pathway [2][3]. Because this process involves the rapid generation of thrombi, the most significant safety concerns associated with its induction are pathological thromboembolic events, including deep vein thrombosis and pulmonary embolism [1][3].

Other names

Blood coagulationHemostatic responseClotting inductionProcoagulant activity

Promotion of blood clot formation through the activation of the coagulation cascade, supplementation of deficient clotting factors, or inhibition of the plasmin-mediated breakdown of fibrin clots.